The opioid antagonist naltrexone inhibits activity and alters expression of α7 and α4β2 nicotinic receptors in hippocampal neurons: implications for smoking cessation programs
- 31 December 2000
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 39 (13) , 2740-2755
- https://doi.org/10.1016/s0028-3908(00)00157-x
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Nicotine at concentrations found in cigarette smokers activates and desensitizes nicotinic acetylcholine receptors in CA1 interneurons of rat hippocampusNeuropharmacology, 2000
- Naltrexone blockade of nicotine effects in cigarette smokersPsychopharmacology, 1999
- Choline and Selective Antagonists Identify Two Subtypes of Nicotinic Acetylcholine Receptors that Modulate GABA Release from CA1 Interneurons in Rat Hippocampal SlicesJournal of Neuroscience, 1999
- Naltrexone Effects on Short-Term and Long-Term Smoking CessationJournal of Addictive Diseases, 1999
- Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco useNeuroscience, 1998
- Allosteric modulation of neuronal nicotinic acetylcholine receptorsJournal of Physiology-Paris, 1998
- Schizophrenia, Sensory Gating, and Nicotinic ReceptorsSchizophrenia Bulletin, 1998
- Molecular and Cellular Aspects of Nicotine AbusePublished by Elsevier ,1996
- α-Bungarotoxin binding sites in rat hippocampal and cortical cultures: initial characterisation, colocalisation with α7 subunits and up-regulation by chronic nicotine treatmentBrain Research, 1995
- Ligand-gated ion channels in the brain: The amino acid receptor superfamilyNeuron, 1990